Where is USV Peptides located?

USV Peptides is headquartered in Mumbai, India. It is registered at Arvind Vithal Gandhi Chowk, B S D Marg, Govandi, Mumbai, Maharashtra, India, 400088.

Which legal entities is USV Peptides associated with?

USV Peptides is associated with USV PRIVATE LIMITED.

How many employees does USV Peptides have?

As of Aug 31, 2025, the latest employee count at USV Peptides is 7131.

What is the annual revenue of USV Peptides?

Annual revenue of USV Peptides is more than ₹1,000 Cr as on Mar 31, 2026

Where does USV Peptides rank among its competitors?

USV Peptides ranks 11th amongst 69 active competitors, of which 6 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Enzene, which secured $50M in Jan, 2023.

Who are the top competitors of USV Peptides?

USV Peptides' top competitors include AmbioPharm, Enzene and PolyPeptide. Among them, Enzene secured the most recent funding round in January, 2023.

USV Peptides - 2026 Company Profile, Competitors & Financials

USV Peptides is an unfunded company based in Mumbai (India). It operates as a CDMO offering custom peptide, GMP peptide and cosmetic peptide synthesis services. USV Peptides has not raised any funding yet. The company has 69 active competitors, including 6 funded and 11 that have exited. Its top competitors include companies like AmbioPharm, Enzene and PolyPeptide.

Company Details

USV is involved in the synthesis of long chain peptides, peptides containing unusual modifications, cyclic peptides and cosmetic peptides. Through their US-FDA approved GMP manufacturing facilities, they provide custom manufacturing services right from research scale to commercial scale. They mainly cater to the needs of drug-discovery and generic peptide formulation companies worldwide. USV's product portfolio includes finished formulations, API, biotherapeutics and peptides.

Website: usvpeptides.com
Social
Registered Address: Arvind Vithal Gandhi Chowk, B S D Marg, Govandi, Mumbai, Maharashtra, India, 400088

Key Metrics

Location

Mumbai, India

Stage

Unfunded

Ranked

11^th among 69 active competitors

Annual Revenue

₹1,000+ Cr as on Mar 31, 2026

Employee Count

7,131 as on Aug 31, 2025

Similar Companies

AmbioPharm & 77 more

View USV Peptides' full profile

USV Peptides is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
USV PRIVATE LIMITED CIN: U24239MH1961PTC012098 , India, Active	Aug 25, 1961	₹1,000+ Cr (As on Mar 31, 2026)	7382 (As on Mar 01, 2026)

USV Peptides has not raised any funding rounds yet.

USV Peptides' employee count trend

USV Peptides has 7,131 employees as of Aug 25. Here is USV Peptides's employee count trend over the years:

Uncover USV Peptides' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of USV Peptides include AmbioPharm, Enzene and PolyPeptide. Here is the list of Top 10 competitors of USV Peptides, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AmbioPharm 2006, North Augusta (United States), Acquired	Peptide manufacturing and development services, setting a new standard worldwide	$24M	The Carlyle Group, MVM & 1 others	58/100
2nd	Enzene 2015, Pune (India), Series C	Company specializing in development of Biosimilars	$50M	F-Prime Capital, Eight Roads Ventures & 1 others	55/100
3rd	PolyPeptide 1952, Baar (Switzerland), Public	CMO manufacturing proprietary,GMP grade and non-GMP-grade peptides	-	-	49/100
4th	Shaanxi Micot Technology 2007, China, Public	Provider of drug research and development services focused on cardiovascular and metabolic diseases	$72.2M	NLVC, Tasly & 2 others	49/100
5th	Hybio Pharmaceutical 1998, Shenzhen (China), Public	Developer and manufacturer of polypeptide drugs and APis	$15M	Shenzhen Capital Group, SAIF Partners & 1 others	43/100
6th	JPT Peptide 2004, Berlin (Germany), Acquired	Peptide based CRO offering proteomics, biomarker and drug discovery services	-	-	40/100
7th	Custom Peptide Synthesis 2011, Mumbai (India), Unfunded	Manufacturer of peptides and other finished formulations, & APIs	-	-	40/100
8th	Proteos Biotech 2010, Madrid (Spain), Unfunded	Manufacturer of recombinant enzymes and provides CMO services	-	-	38/100
9th	Rameda 1994, Giza (Egypt), Public	Developer and manufacturer of generic pharmaceuticals, nutraceuticals, food supplements and veterinary products	-	Public Investment Fund, Compass Capital	37/100
10th	CPC Scientific 2001, Sunnyvale (United States), Unfunded	Company offering peptide development and manufacturing services for clinical and commercial applications	-	-	36/100
11th	USV Peptides Mumbai (India), Unfunded	CDMO offering custom peptide, GMP peptide and cosmetic peptide synthesis services	-	-	35/100